Interest is rising in life‑science pipelines, and companies that succeed combine strong science with disciplined financial and operational foundations.
For decades, companies have navigated the complexities involved in deducting research and experimental expenditures. The One Big Beautiful Bill (OBBB) Act with the newly released...
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the...
Understanding the U.S. Market Entry Process for Life Science Companies For foreign life sciences companies, the decision to establish a presence in the United States...
The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, introduces broad changes to international tax rules. These adjustments will affect U.S. corporations with...
Life science companies, particularly those in the start-up or growth phase, are challenged with balancing their core mission, e.g., advancing scientific discovery, with the complex...
Could your startup benefit from research and development (R&D) tax credits? Have you explored whether or not you qualify? Are you prepared to navigate tax...
In this article: Federal Tax Updates and Credits Expiring Provisions in the Tax Cuts and Jobs Act State Tax Challenges and Compliance International Tax Strategy...
Webinar: Year-End Tax Planning & Compliance for Privately Held Companies AAFCPAs invites you to watch our 2024 Business Tax Planning webinar, designed to provide essential...
